Axxcess Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Sell |
10,418
-1,568
| -13% | -$174K | 0.03% | 394 |
|
2025
Q1 | $1.34M | Sell |
11,986
-1,314
| -10% | -$147K | 0.04% | 328 |
|
2024
Q4 | $1.23M | Sell |
13,300
-998
| -7% | -$92.2K | 0.03% | 367 |
|
2024
Q3 | $1.2M | Sell |
14,298
-5,448
| -28% | -$457K | 0.03% | 354 |
|
2024
Q2 | $1.35M | Buy |
19,746
+1,830
| +10% | +$126K | 0.04% | 322 |
|
2024
Q1 | $1.31M | Buy |
17,916
+3,521
| +24% | +$258K | 0.04% | 321 |
|
2023
Q4 | $1.17M | Sell |
14,395
-504
| -3% | -$40.8K | 0.03% | 325 |
|
2023
Q3 | $1.12M | Buy |
14,899
+5,674
| +62% | +$425K | 0.04% | 299 |
|
2023
Q2 | $711K | Sell |
9,225
-7,507
| -45% | -$579K | 0.05% | 280 |
|
2023
Q1 | $1.39M | Buy |
16,732
+1,059
| +7% | +$87.9K | 0.11% | 179 |
|
2022
Q4 | $1.35M | Buy |
15,673
+6,910
| +79% | +$593K | 0.11% | 177 |
|
2022
Q3 | $541K | Buy |
8,763
+4,158
| +90% | +$257K | 0.05% | 301 |
|
2022
Q2 | $285K | Sell |
4,605
-3,873
| -46% | -$240K | 0.03% | 405 |
|
2022
Q1 | $504K | Buy |
8,478
+2,006
| +31% | +$119K | 0.04% | 352 |
|
2021
Q4 | $470K | Buy |
+6,472
| New | +$470K | 0.03% | 371 |
|